Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series-Reference-Cited by-同舟云学术

Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series

Published:2006-11-09 Issue:3 Volume:17 Page:684-692
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Choi Dongil,Lim Hyo K.,Rhim Hyunchul,Kim Young-sun,Lee Won Jae,Paik Seung Woon,Koh Kwang Cheol,Lee Joon Hyoek,Choi Moon Seok,Yoo Byung Chul

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-006-0461-5.pdf

Reference28 articles.

1. Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15(5):948–963

2. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362(9399):1907–1917

3. Song TJ, Ip EW, Fong Y (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127(5 Suppl 1):248–260

4. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30(6):1434–1440

5. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM (2005) Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 31(4):331–347

Cited by 282 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal trends and long-term outcomes of radiofrequency ablation for hepatocellular carcinoma within the Milan criteria;Scientific Reports;2024-08-27

2. Consequence of Red Blood Cells Deformability on Heat Sink Effect of Blood in a Three-Dimensional Bifurcated Vessel;Journal of Biomechanical Engineering;2024-04-08

3. A model for predicting risk of early recurrence in patients undergoing radiofrequency ablation for early-stage hepatocellular carcinoma;2024-02-16

4. Percutaneous Radiofrequency Ablation in the Treatment of Primary Liver Cancers;Interventional Oncology;2023-11-30

5. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial;The Lancet;2023-11